MeSH tree: C23.888.144
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and feel full sooner. Their ...
Mar 14, 2026
0
0
Diet‑related diseases such as type 2 diabetes, obesity and hypertension, particularly those affecting children, remain stubbornly high. Can public policies like those that have been successful with tobacco control help ...
Mar 13, 2026
0
0
As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 patients suggests that discontinuing ...
Mar 13, 2026
0
0
Many teens dealing with weight issues are turning to AI models to help them create meal plans with the aim of losing weight. But a new study shows that the resulting plans may not always adequately cover necessary nutrients ...
Mar 12, 2026
0
0
Instances of insomnia are on the rise globally, which is a matter of great concern, as lack of sleep can take a heavy toll on one's physical and mental health. A recent study by The Education University of Hong Kong investigated ...
Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the hormone asprosin influences long-term weight change among postmenopausal women in the United States. ...
Mar 11, 2026
0
0
Analysis of a large, nationally representative survey shows that stroke survivors under age 50 have more problems concentrating and running errands and experience more poor mental health days than older stroke survivors do. ...
Mar 10, 2026
0
0
Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to a new study by UT Southwestern ...
Mar 10, 2026
0
0
Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescriptions increased from 2018 to 2025, while MBS use decreased beginning in 2023, according to a research ...
Mar 10, 2026
0
0
Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater increase in risk for liver fibrosis than men with the same risk factors. The study, just published in ...
Mar 9, 2026
0
0
